50% off the $29.99 Customized Fix Kit. Use at checkout:
⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
LYMPHIR™ (denileukin diftitox
What this score means
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. LYMPHIR™ (denileukin diftitox just got measured.
5/10 means LYMPHIR™ (denileukin diftitox is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
About LYMPHIR™ (denileukin diftitox
LYMPHIR™ (denileukin diftitox-cxdl) is indicated for the treatment of adult patients with relapsed or refractory Stage I-III cutaneous T-cell lymphoma after at least one prior systemic therapy. Read more and sign up for updates.
Key Topics
Details
Industry: Technology
lymphirhcp.comAI Visibility Breakdown
2
Structured Data
7
Content Structure
6
Entity Clarity
4
E-E-A-T Signals
7
Technical AEO
2
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
Tech Shoppers Do More Research Than Anyone. Are You There When They're Looking?
Tech buyers are the most research-intensive shoppers on the internet.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for LYMPHIR™ (denileukin diftitox.
Source & Attribution
Scored by Engagemii on July 9, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/lymphirhcp
Cite this score: Engagemii (2026). "AEO Score for LYMPHIR™ (denileukin diftitox." Retrieved from https://engagemii.com/aeo/brands/lymphirhcp
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform